Vojdani et al. (Lyons-Weiler) showed us potential risk for autoimmunity & multi-system disorders (molecular mimicry) with COVID (& mRNA vaccine) that may come from cross-reactivity between our human

tissues and this dreaded COVID virus antibodies (& vaccine antibodies) & thus underscores why we are angry & clamouring about the lack of safety testing of the mRNA vaccine in this autoimmunity regard

FRONTIERS:

‘Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases’

Researchers aimed to assess ‘whether immune reactivity occurs between anti-SARS-CoV-2 protein antibodies and human tissue antigens (and we can extrapolate to mRNA technology vaccine (& DNA platform ‘added’), and whether molecular mimicry between COVID-19 viral proteins and human tissues could be the cause’.

Researchers ‘applied both human monoclonal anti-SARS-Cov-2 antibodies (spike protein, nucleoprotein) and rabbit polyclonal anti-SARS-Cov-2 antibodies (envelope protein, membrane protein) to 55 different tissue antigens.’

They ‘found that SARS-CoV-2 antibodies had reactions with 28 out of 55 tissue antigens, representing a diversity of tissue groups that included barrier proteins, gastrointestinal, thyroid and neural tissues, and more.’

They ‘also did selective epitope mapping using BLAST and showed similarities and homology between spike, nucleoprotein, and many other SARS-CoV-2 proteins with the human tissue antigens mitochondria M2, F-actin and TPO.

This extensive immune cross-reactivity between SARS-CoV-2 antibodies and different antigen groups may play a role in the multi-system disease process of COVID-19 (and vaccine), influence the severity of the disease, precipitate the onset of autoimmunity in susceptible subgroups, and potentially exacerbate autoimmunity in subjects that have pre-existing autoimmune diseases.

Very recently, human monoclonal antibodies were approved for use on patients with COVID-19. The human monoclonal antibodies used in this study are almost identical with these approved antibodies. Thus…’results can establish the potential risk for autoimmunity and multi-system disorders with COVID-19 that may come from cross-reactivity between our own human tissues and this dreaded virus (and mRNA vaccine ‘added’).

https://www.frontiersin.org/articles/10.3389/fimmu.2020.617089/full

ORIGINAL RESEARCH article

Front. Immunol., 19 January 2021
Sec. Autoimmune and Autoinflammatory Disorders
Volume 11 - 2020 | https://doi.org/10.3389/fimmu.2020.617089